🧵 1. U.S. drugmaker Eli Lilly appoints insider Lucas Montarce as new CFO amid soaring demand for diabetes and weight loss drugs. Former CFO joined Google. #business
🧵 1. U.S. drugmaker Eli Lilly appoints insider Lucas Montarce as new CFO amid soaring demand for diabetes and weight loss drugs. Former CFO joined Google. #business
🧵 2. Eli Lilly and Novo Nordisk lead the growing weight loss drug market. Lilly raised its annual forecast by $3 billion as it expands manufacturing capacity.
🧵 3. Shares of Eli Lilly rose 1% in premarket trading following the executive change. The company remains on the FDA's drug shortage list.
🧵 4. Montarce, who joined Lilly in 2001, will serve as CFO and executive VP. His base salary is $1 million, with eligibility for a $1 million bonus.
🧵 5. Lilly's weight-loss treatments continue to face overwhelming demand. Novo Nordisk missed expectations in the latest quarter in this competitive market.
🧵 Read more at: https://www.cnbc.com/2024/09/09/eli-lilly-names-insider-lucas-montarce-as-new-finance-chief.html